Expertise in
6
conditions

Satoshi Hamauchi

Department Of Head And Neck Medical Oncology, 1007 Shimonagakubo, Nagaizumi, Sunto Gun, 
Shimonagakubo, JP 
Expertise in
6
conditions
Department Of Head And Neck Medical Oncology, 1007 Shimonagakubo, Nagaizumi, Sunto Gun, 
Shimonagakubo, JP 

Overview

Satoshi Hamauchi practices practicing medicine in Shimonagakubo, Japan.

Mr. Hamauchi is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Stomach Cancer, Esophageal Cancer, Gastrostomy, and Stent Placement.

He is actively involved in clinical research, co-authoring 61 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Department Of Head And Neck Medical Oncology, 1007 Shimonagakubo, Nagaizumi, Sunto Gun, Shimonagakubo, 4118777, Japan
Other Locations
Shizuoka, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-Blind, Adaptive, Phase II/III Study of GSK3359609 in Combination With Pembrolizumab and 5FU-Platinum Chemotherapy Versus Placebo in Combination With Pembrolizumab Plus 5FU-Platinum Chemotherapy for First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Randomized, Double-Blind, Adaptive, Phase II/III Study of GSK3359609 in Combination With Pembrolizumab and 5FU-Platinum Chemotherapy Versus Placebo in Combination With Pembrolizumab Plus 5FU-Platinum Chemotherapy for First-Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drugs: Feladilimab, Pembrolizumab, Fluorouracil, Cisplatin, Carboplatin
Study Phase: Phase 3

61 Total Publications

Correction: Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.
Correction: Multimodal treatments for patients with locally advanced synchronous esophageal and head and neck cancer.
Journal: International journal of clinical oncology
Published: July 09, 2026

Frequently Asked Questions about Satoshi Hamauchi

Is Satoshi Hamauchi a top-rated expert for Head and Neck Squamous Cell Carcinoma (HNSCC)?

MediFind is an objective health platform that identifies experts based on real-world data. Satoshi Hamauchi is classified as an Advanced expert for Head and Neck Squamous Cell Carcinoma (HNSCC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Satoshi Hamauchi participate in research or clinical trials?

Yes. Satoshi Hamauchi has published 61 articles and abstracts on conditions like Head and Neck Squamous Cell Carcinoma (HNSCC). You can view a list of Satoshi Hamauchi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hamauchi's expertise for a condition
ConditionClose
      View All 12 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile